Cargando…
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease.
The collagen crosslinks, pyridinoline and deoxypyridinoline, are recently described markers of the rate of bone resorption. The urinary excretion of these compounds, expressed as a ratio to urinary creatinine, has been measured using ion-pair reversed phase high-performance liquid chromatography in...
Autores principales: | Coleman, R. E., Houston, S., James, I., Rodger, A., Rubens, R. D., Leonard, R. C., Ford, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977378/ https://www.ncbi.nlm.nih.gov/pubmed/1586605 |
Ejemplares similares
-
Pyridinium crosslinks as markers of bone resorption in patients with breast cancer.
por: Paterson, C. R., et al.
Publicado: (1991) -
Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion
por: Vinholes, J, et al.
Publicado: (1999) -
Urinary Excretion of Antimony after Administration of Methyl Glucamine Antimoniate. Preliminary Observations
por: Chakravarti, R. N., et al.
Publicado: (1950) -
Collagen crosslink excretion and staging of oral cancer
por: Springer, I N G, et al.
Publicado: (2003) -
Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer
por: Dulong, S., et al.
Publicado: (2021)